These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9482531)

  • 1. The infectious complications of chronic lymphocytic leukemia.
    Morrison VA
    Semin Oncol; 1998 Feb; 25(1):98-106. PubMed ID: 9482531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches.
    Morrison VA
    Best Pract Res Clin Haematol; 2010 Mar; 23(1):145-53. PubMed ID: 20620978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infectious complications of chronic lymphocytic leukemia.
    Wadhwa PD; Morrison VA
    Semin Oncol; 2006 Apr; 33(2):240-9. PubMed ID: 16616071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population.
    Perkins JG; Flynn JM; Howard RS; Byrd JC
    Cancer; 2002 Apr; 94(7):2033-9. PubMed ID: 11932906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis.
    Morrison VA
    Clin Lymphoma Myeloma; 2009 Oct; 9(5):365-70. PubMed ID: 19858055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on prophylaxis and therapy of infection in patients with chronic lymphocytic leukemia.
    Morrison VA
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):84-90. PubMed ID: 12113137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immune globulin in chronic lymphocytic leukaemia.
    Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic strategies to meet infectious complications in fludarabine-treated CLL.
    Südhoff T; Arning M; Schneider W
    Leukemia; 1997 Apr; 11 Suppl 2():S38-41. PubMed ID: 9178837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the treatment of chronic lymphocytic leukemia: defining the role of intravenous immunoglobulin.
    Besa EC
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):14-23. PubMed ID: 1380736
    [No Abstract]   [Full Text] [Related]  

  • 10. Infection and immunity in chronic lymphocytic leukemia.
    Tsiodras S; Samonis G; Keating MJ; Kontoyiannis DP
    Mayo Clin Proc; 2000 Oct; 75(10):1039-54. PubMed ID: 11040852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of infectious complications in patients with chronic lymphocytic leukemia.
    Morrison VA
    Hematology Am Soc Hematol Educ Program; 2007; ():332-8. PubMed ID: 18024648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy.
    Marotta G; Bigazzi C; Lenoci M; Tozzi M; Bocchia M; Lauria F
    Haematologica; 2000 Dec; 85(12):1268-70. PubMed ID: 11114133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia.
    Kay NE
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S50-4. PubMed ID: 16549115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid resolution of Mycobacterium marinum chronic skin infection during lenalidomide therapy for chronic lymphocytic leukemia.
    Awais A; Tam CS; Kontoyiannis D; Ferrajoli A; Duvic M; Cortes J; Keating MJ
    Clin Infect Dis; 2008 Apr; 46(7):e69-71. PubMed ID: 18444808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I and II study of pentostatin (Nipent) with cyclophosphamide for previously treated patients with chronic lymphocytic leukemia.
    Weiss MA
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):41-3. PubMed ID: 10877051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapsing pure red cell aplasia associated with B-cell chronic lymphocytic leukemia successfully treated by intravenous immunoglobulin concentrate.
    Castelli R; Vismara A; Pavia G; Dagani R; Porro T
    Ann Ital Med Int; 2002; 17(1):47-50. PubMed ID: 11975114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose methylprednisolone and rituximab is an effective therapy in advanced refractory chronic lymphocytic leukemia resistant to fludarabine therapy.
    Dungarwalla M; Evans SO; Riley U; Catovsky D; Dearden CE; Matutes E
    Haematologica; 2008 Mar; 93(3):475-6. PubMed ID: 18310545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symposium on infections in the compromised host. The leukemias.
    Newman KA
    Nurs Clin North Am; 1985 Mar; 20(1):227-34. PubMed ID: 3919366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nursing guidelines for managing infections in patients with chronic lymphocytic leukemia.
    Moran M; Browning M; Buckby E
    Clin J Oncol Nurs; 2007 Dec; 11(6):914-24. PubMed ID: 18063549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.